Excessive alcohol consumption can lead to harmful and deadly ethanol poisoning in the body. Current treatment options are limited, but researchers will find a new use for a device that treats carbon monoxide poisoning. It essentially allows the person to hyperventilation safely without getting out.
The device is the clearer of Thurnhill Medical, a for-profit spin-spin company of the University Health Network in Canada. A study of the device found that hyperventilation removes alcohol from the body at least three times faster through the liver alone, the UN said in a statement on Thursday.
Loss of carbon dioxide when hyperventilating can lead to stupidity. Clearmate solves these problems by returning carbon dioxide to the patient through a face mask. This allows the lungs to inhale ethanol from alcohol intoxication, reducing its presence in the blood.
While it seems like this device may be popular for people who party a lot, here are some serious medical tricks. The UNHA said it could “be a game-changer in preventive therapy for severe alcohol intoxication, as well as simply ‘self-destruct.’
The human gallbladder handles the task of clearing alcohol from the human system effectively, but it can only work so quickly. U.N.H.N. That said, this life-threatening alcohol level measures oxygen, intravenous fluids, breathing aids and treatment of any heart issues with medications.
“This is a very basic, low-tech device that can be built anywhere in the world: no electronics, no computers or filters,” said Joseph Fisher, co-founder of Thrnhill Medical. “It’s almost indescribable why we didn’t try this decades ago.”
The device was previously approved by the FDA for marketing in 2019 as a treatment for carbon monoxide poisoning.
The team published its findings this month in the journal Scientific Reports, entitled “Accelerated Ethanol Elimination from the Lungs.” This study was only a testament to the concept with five volunteers, so Clearmate has not yet been cleared for use in the treatment of alcoholism.
Researchers are recommending follow-up studies with the goal of going into clinical trials.